Fielmann (FRA:FIE) received a €41.00 ($47.67) target price from equities research analysts at Hauck & Aufhaeuser in a research note issued on Friday, Borsen Zeitung reports. The brokerage currently has a “sell” rating on the stock. Hauck & Aufhaeuser’s price target would suggest a potential downside of 34.92% from the company’s previous close.
Other research analysts also recently issued research reports about the stock. Warburg Research set a €47.00 ($54.65) price target on shares of 1&1 Drillisch and gave the stock a “buy” rating in a research report on Tuesday, July 2nd. Baader Bank set a €72.00 ($83.72) price target on shares of Fielmann and gave the stock a “buy” rating in a research report on Wednesday, May 29th. Independent Research set a €72.00 ($83.72) price target on shares of Fielmann and gave the stock a “neutral” rating in a research report on Thursday. Berenberg Bank restated a “sell” rating and set a GBX 600 ($7.84) price target on shares of Great Portland Estates in a research report on Wednesday, May 22nd. Finally, DZ Bank restated a “buy” rating on shares of Talanx in a research report on Thursday, May 9th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of €60.41 ($70.24).
FIE opened at €63.00 ($73.26) on Friday. Fielmann has a twelve month low of €65.50 ($76.16) and a twelve month high of €77.50 ($90.12). The stock’s 50-day moving average is €63.68.
Fielmann Aktiengesellschaft invests in and operates optical and hearing aid businesses in Germany, Switzerland, Austria, and internationally. The company designs, manufactures, distributes, and retails visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses, and related articles and accessories, as well as hearing aids and accessories.
Read More: Is it Safe to Invest in Commodities?
Receive News & Ratings for Fielmann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fielmann and related companies with MarketBeat.com's FREE daily email newsletter.